Boston Scientific Corpora... (BSX)

In the latest trading session, Boston Scientific (BSX) closed at $106.66, marking a +1.1% move from the previous day.

For biotech firms, a bit of positive news—a key result from clinical trials or new drug discovery, say—can be the difference between a major rally based on a path toward sustained profitability and a ...

Two MedTech giants, one clear winner. Boston Scientific's momentum outpaces Hologic's cautious rise.

Uber, JPMorgan and RTX are stocks to watch. The market jumped Friday as Fed chief Powell hinted at rate cuts.

BSX's global expansion and MedSurg growth boost Q2 momentum, though currency and macro headwinds weigh on the same.

AI-driven innovations in medical devices are fueling growth for BSX, JNJ, GEHC and TEM.

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often ...

Here is how Boston Scientific (BSX) and Amneal Pharmaceuticals (AMRX) have performed compared to their sector so far this year.

Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.